Press release
Diabetic Nephropathy-Pipeline Review H2 2017
ReportsWeb
Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary modification.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Diabetic Nephropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 14, 10, 1, 32, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 3 molecules, respectively.
Diabetic Nephropathy (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/diabetic-nephropathy-pipeline-review-h2-2017
Report Scope
-The pipeline guide provides a snapshot of the global therapeutic landscape of Diabetic Nephropathy (Metabolic Disorders).
-The pipeline guide reviews pipeline therapeutics for Diabetic Nephropathy (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
-The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
-The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
-The pipeline guide reviews key companies involved in Diabetic Nephropathy (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
-The pipeline guide evaluates Diabetic Nephropathy (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
-The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
-The pipeline guide reviews latest news related to pipeline therapeutics for Diabetic Nephropathy (Metabolic Disorders)
Request a sample copy at http://www.reportsweb.com/inquiry&RW00011022675/sample
Reasons to buy
-Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
-Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Find and recognize significant and varied types of therapeutics under development for Diabetic Nephropathy (Metabolic Disorders).
-Classify potential new clients or partners in the target demographic.
-Develop tactical initiatives by understanding the focus areas of leading companies.
-Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
-Formulate corrective measures for pipeline projects by understanding Diabetic Nephropathy (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
-Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
-Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
AbbVie Inc
Allergan Plc
Antisense Therapeutics Ltd
Aptevo Therapeutics Inc
Araim Pharmaceuticals Inc
Arena Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca Plc
Bayer AG
BLR Bio LLC
Boehringer Ingelheim GmbH
Cellmid Ltd
ChemoCentryx Inc
CSL Ltd
Daiichi Sankyo Company Ltd
DiaMedica Therapeutics Inc
Dynamis Therapeutics Inc
Galectin Therapeutics Inc
.Ask for Discount at http://www.reportsweb.com/inquiry&RW00011022675/discount
List of Tables
Number of Products under Development for Diabetic Nephropathy, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Diabetic Nephropathy-Pipeline by AbbVie Inc, H2 2017
Diabetic Nephropathy-Pipeline by Allergan Plc, H2 2017
Diabetic Nephropathy-Pipeline by Antisense Therapeutics Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Aptevo Therapeutics Inc, H2 2017
Diabetic Nephropathy-Pipeline by Araim Pharmaceuticals Inc, H2 2017
Diabetic Nephropathy-Pipeline by Arena Pharmaceuticals Inc, H2 2017
Diabetic Nephropathy-Pipeline by Astellas Pharma Inc, H2 2017
Diabetic Nephropathy-Pipeline by AstraZeneca Plc, H2 2017
Diabetic Nephropathy-Pipeline by Bayer AG, H2 2017
Diabetic Nephropathy-Pipeline by BLR Bio LLC, H2 2017
Diabetic Nephropathy-Pipeline by Boehringer Ingelheim GmbH, H2 2017
Diabetic Nephropathy-Pipeline by Cellmid Ltd, H2 2017
Diabetic Nephropathy-Pipeline by ChemoCentryx Inc, H2 2017
Diabetic Nephropathy-Pipeline by CSL Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Daiichi Sankyo Company Ltd, H2 2017
Diabetic Nephropathy-Pipeline by DiaMedica Therapeutics Inc, H2 2017
Diabetic Nephropathy-Pipeline by Dynamis Therapeutics Inc, H2 2017
Diabetic Nephropathy-Pipeline by Galectin Therapeutics Inc, H2 2017
Diabetic Nephropathy-Pipeline by GenKyoTex SA, H2 2017
Diabetic Nephropathy-Pipeline by Gilead Sciences Inc, H2 2017
Diabetic Nephropathy-Pipeline by GNI Group Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Islet Sciences Inc, H2 2017
Diabetic Nephropathy-Pipeline by Johnson & Johnson, H2 2017
Diabetic Nephropathy-Pipeline by MediPost Co Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Mesoblast Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017
Diabetic Nephropathy-Pipeline by MorphoSys AG, H2 2017
Diabetic Nephropathy-Pipeline by Noxxon Pharma AG, H2 2017
Diabetic Nephropathy-Pipeline by Omeros Corp, H2 2017
Diabetic Nephropathy-Pipeline by Paranta Biosciences Ltd, H2 2017
Diabetic Nephropathy-Pipeline by PhiloGene Inc, H2 2017
Diabetic Nephropathy-Pipeline by PhytoHealth Corp, H2 2017
Diabetic Nephropathy-Pipeline by ProMetic Life Sciences Inc, H2 2017
Diabetic Nephropathy-Pipeline by Redx Pharma Plc, H2 2017
Diabetic Nephropathy-Pipeline by Sarfez Pharmaceuticals Inc, H2 2017
Diabetic Nephropathy-Pipeline by Serodus ASA, H2 2017
Diabetic Nephropathy-Pipeline by Teijin Pharma Ltd, H2 2017
Diabetic Nephropathy-Pipeline by Theravance Biopharma Inc, H2 2017
Diabetic Nephropathy-Pipeline by Twoxar Inc, H2 2017
Diabetic Nephropathy-Pipeline by Vascular Pharmaceuticals Inc, H2 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW00011022675/buy/2000
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support Vulvar Cancer is always available to help you on your research queries.
505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Nephropathy-Pipeline Review H2 2017 here
News-ID: 692166 • Views: …
More Releases from ReportsWeb
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this…
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during…
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during…
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles
Summary
"Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy.
The report provides in depth analysis on global renewable power market and…
More Releases for Diabetic
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview
Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting…
Global Diabetic Footwear Market Is Driven By Growing Diabetic Patients Worldwide
Global Diabetic Footwear Market Report, published by Variant Market Research, forecast that the global market is expected to reach $9.4 Billion by 2024 from $5.3 Billion in 2016; growing at a CAGR of 7.4% from 2016 to 2024.
To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/consumer-goods/diabetic-footwear-market
Diabetic footwears are used to reduce foot amputation and ulceration risk in people suffering from diabetes. It is a lifestyle disease. Foot ulceration and debilitating…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
